Research
The landscape of radiotherapeutic and molecular imaging strategies is rapidly evolving, yet translating biological insight into precise diagnostic and therapeutic tools remains complex. Our laboratory develops small-molecule probes and radiolabeled platforms that integrate chemical biology, quantitative imaging, positron emission tomography, and computational modeling to better understand and treat disease. We design approaches that are mechanistically rigorous, broadly applicable, and grounded in reproducible science to advance impactful translational research.
–>
All
2025
An Inhibitor of Death-Associated Protein Kinase 3 (DAPK3) Disrupts Hippo Signaling and Intestinal Epithelial Regeneration in Murine DSS-Induced Colitis
Digestive Diseases and Sciences
·
07 Nov 2025
·
doi:10.1007/s10620-025-09505-x
2024
Transforming Growth Factor-β-Activated Kinase 1 (TAK1) Alleviates Inflammatory Joint Pain in Osteoarthritis and Gouty Arthritis Preclinical Models
Journal of Pain Research
·
01 Jun 2024
·
doi:10.2147/JPR.S451409
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers
Cell Death & Disease
·
17 Apr 2024
·
doi:10.1038/s41419-024-06654-1
Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome
Cell Chemical Biology
·
01 Apr 2024
·
doi:10.1016/j.chembiol.2024.02.008
Cooperative involvement of zipper-interacting protein kinase (ZIPK) and the dual-specificity cell-division cycle 14A phosphatase (CDC14A) in vascular smooth muscle cell migration
openRxiv
·
09 Mar 2024
·
doi:10.1101/2024.03.06.583600
Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development
Cell Chemical Biology
·
01 Mar 2024
·
doi:10.1016/j.chembiol.2023.10.004
2023
Investigation of SARS-CoV-2 individual proteins reveals the in vitro and in vivo immunogenicity of membrane protein
Scientific Reports
·
18 Dec 2023
·
doi:10.1038/s41598-023-49077-2
Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis
JCI Insight
·
24 Jul 2023
·
doi:10.1172/jci.insight.165358
2022
Expression of membrane Hsp90 is a molecular signature of T cell activation
Scientific Reports
·
27 Oct 2022
·
doi:10.1038/s41598-022-22788-8
Development and Efficacy of an Orally Bioavailable Selective TAK1 Inhibitor for the Treatment of Inflammatory Arthritis
ACS Chemical Biology
·
02 Mar 2022
·
doi:10.1021/acschembio.1c00788
2021
Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells
iScience
·
01 Dec 2021
·
doi:10.1016/j.isci.2021.103412
Expression of ectopic heat shock protein 90 in male and female primary afferent nociceptors regulates inflammatory pain
Pain
·
12 Oct 2021
·
doi:10.1097/j.pain.0000000000002511
Understanding the sources of errors in ex vivo Hsp90 molecular imaging for rapid-on-site breast cancer diagnosis
Biomedical Optics Express
·
23 Mar 2021
·
doi:10.1364/BOE.418818
2020
TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
Open Biology
·
01 Sep 2020
·
doi:10.1098/rsob.200099
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors
Communications Biology
·
08 May 2020
·
doi:10.1038/s42003-020-0956-7
A highly selective inhibitor of interleukin-1 receptor–associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase
Journal of Biological Chemistry
·
01 Feb 2020
·
doi:10.1074/jbc.RA119.011857
2019
Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice
Arthritis Research & Therapy
·
01 Dec 2019
·
doi:10.1186/s13075-019-2073-x
Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer
Scientific Reports
·
05 Mar 2019
·
doi:10.1038/s41598-019-40252-y
2018
Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development
Cell Stress and Chaperones
·
01 Jul 2018
·
doi:10.1007/s12192-018-0877-2
Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity
Antimicrobial Agents and Chemotherapy
·
01 Apr 2018
·
doi:10.1128/AAC.01799-17
2017
In Vivo
Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
Clinical Cancer Research
·
14 Dec 2017
·
doi:10.1158/1078-0432.CCR-17-1453
Fluorescent-Linked Enzyme Chemoproteomic Strategy (FLECS) for Identifying HSP70 Inhibitors
Methods in Molecular Biology
·
26 Nov 2017
·
doi:10.1007/978-1-4939-7477-1_6
Near-simultaneous intravital microscopy of glucose uptake and mitochondrial membrane potential, key endpoints that reflect major metabolic axes in cancer
Scientific Reports
·
23 Oct 2017
·
doi:10.1038/s41598-017-14226-x
Cellular fatty acid synthase is required for late stages of HIV-1 replication
Retrovirology
·
29 Sep 2017
·
doi:10.1186/s12977-017-0368-z
A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo
ACS Chemical Biology
·
23 Feb 2017
·
doi:10.1021/acschembio.7b00006
2016
An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target
Antiviral Research
·
01 Jun 2016
·
doi:10.1016/j.antiviral.2016.03.017
Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2 + Breast Cancer
Cell Chemical Biology
·
01 Jun 2016
·
doi:10.1016/j.chembiol.2016.04.011
2015
Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice
Journal of Biological Chemistry
·
01 Jul 2015
·
doi:10.1074/jbc.M115.658120
2014
Identification of an Allosteric Small-Molecule Inhibitor Selective for the Inducible Form of Heat Shock Protein 70
Chemistry & Biology
·
01 Dec 2014
·
doi:10.1016/j.chembiol.2014.10.016
2013
Fluorescence Linked Enzyme Chemoproteomic Strategy for Discovery of a Potent and Selective DAPK1 and ZIPK Inhibitor
ACS Chemical Biology
·
17 Oct 2013
·
doi:10.1021/cb400407c
Optical and Radioiodinated Tethered Hsp90 Inhibitors Reveal Selective Internalization of Ectopic Hsp90 in Malignant Breast Tumor Cells
Chemistry & Biology
·
01 Sep 2013
·
doi:10.1016/j.chembiol.2013.08.004
Hsp90, an unlikely ally in the war on cancer
The FEBS Journal
·
24 Feb 2013
·
doi:10.1111/febs.12147
2012
A highly selective Hsp90 affinity chromatography resin with a cleavable linker
Bioorganic & Medicinal Chemistry
·
01 May 2012
·
doi:10.1016/j.bmc.2012.03.043
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer
Breast Cancer Research
·
17 Apr 2012
·
doi:10.1186/bcr3168
2011
Smoothelin-like 1 Protein Is a Bifunctional Regulator of the Progesterone Receptor during Pregnancy
Journal of Biological Chemistry
·
01 Sep 2011
·
doi:10.1074/jbc.M111.270397
Phosphorylation-dependent control of ZIPK nuclear import is species specific
Cellular Signalling
·
01 Jan 2011
·
doi:10.1016/j.cellsig.2010.09.016
2010
Smoothelin-like 1 Protein Regulates Myosin Phosphatase-targeting Subunit 1 Expression during Sexual Development and Pregnancy*
Journal of Biological Chemistry
·
01 Sep 2010
·
doi:10.1074/jbc.M110.143966
Application of Chemoproteomics to Drug Discovery: Identification of a Clinical Candidate Targeting Hsp90
Chemistry & Biology
·
01 Jul 2010
·
doi:10.1016/j.chembiol.2010.04.015
2008
Deletion of the Protein Kinase A/Protein Kinase G Target SMTNL1 Promotes an Exercise-adapted Phenotype in Vascular Smooth Muscle
Journal of Biological Chemistry
·
01 Apr 2008
·
doi:10.1074/jbc.M708628200
Murine CD7 Shares Antigenic Cross-Reactivity with HSP-60
Hybridoma
·
01 Apr 2008
·
doi:10.1089/hyb.2007.0553